Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Research Article

Antibiogram of Urinary Enterococcus Isolates from a Tertiary Care Hospital

Author(s): Nanditha Rajaram Bhat, Shruthi Bhat Kodur Shivashankar and Biranthabail Dhanashree*

Volume 21, Issue 1, 2021

Published on: 03 April, 2020

Page: [146 - 150] Pages: 5

DOI: 10.2174/1871526520666200403140618

Price: $65

Abstract

Purpose: Urinary tract infection (UTI) is one of the serious infections caused by the bacteria Enterococci. Vancomycin-Resistant Enterococci (VRE) is a persevering clinical problem globally. This study aims to detect high-level aminoglycoside and vancomycin resistance in uropathogenic Enterococcus spp.

Methodology: A total of 75 clinically relevant Enterococcus spp. grown from urine samples, were collected following convenience non-random sampling method. Identified by standard biochemical tests and susceptibility to antibiotics was studied by Kirby Bauer’s disc diffusion method. The MIC of vancomycin was detected by agar dilution test. Van A, and Van B genes in VREs were detected by PCR.

Results: Among 75 Enterococcal isolates, 43 (57.3%) were E. faecalis, 12 (16%) were E. faecium, 6 (8%) of each were E. pseudoavium and E. casseliflavus, 5(6.66%) were E. dispar and 3 (4%) were E. durans. E. faecalis (n=19) and E. faecium (n=3) were resistant to High Level Streptomycin (HLS). E. faecalis (n=21) and E. faecium (n=6) were resistant to High Level Gentamicin (HLG). 4 (9.3%) E. faecalis were vancomycin-resistant, out of which 3 were of Van A, and one was both Van A and Van B genotype.

Conclusion: Isolation of high level aminoglycoside resistant (HLAR) Enterococci is a challenge for the treating physician because aminoglycoside cannot be used in combination with glycopeptide or ampicillin for such isolates. The occurrence of HLAR, Van A, and Van B VRE genotypes is a cause of concern as they may transfer drug resistance genes to other bacterial isolates, thus leading to limited therapeutic options.

Keywords: Antibiotics, vancomycin resistant enterococci, Enterococcus faecalis, Enterococcus faecium, PCR.Urinary Enterococcus

Graphical Abstract

[1]
Ahmed, M.O.; Baptiste, K.E. Vancomycin-resistant enterococci: A review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microb. Drug Resist., 2018, 24(5), 590-606.
[http://dx.doi.org/10.1089/mdr.2017.0147] [PMID: 29058560]
[2]
Kampmeier, S.; Kossow, A.; Clausen, L.M.; Knaack, D.; Ertmer, C.; Gottschalk, A.; Freise, H.; Mellmann, A. Hospital acquired vancomycin resistant enterococci in surgical intensive care patients - a prospective longitudinal study. Antimicrob. Resist. Infect. Control, 2018, 7, 103.
[http://dx.doi.org/10.1186/s13756-018-0394-1] [PMID: 30155243]
[3]
Raza, T.; Ullah, S.R.; Mehmood, K.; Andleeb, S. Vancomycin resistant Enterococci: A brief review. J. Pak. Med. Assoc., 2018, 68(5), 768-772.
[PMID: 29885179]
[4]
Heuer, O.E.; Hammerum, A.M.; Collignon, P.; Wegener, H.C. Human health hazard from antimicrobial-resistant enterococci in animals and food. Clin. Infect. Dis., 2006, 43(7), 911-916.
[http://dx.doi.org/10.1086/507534] [PMID: 16941376]
[5]
Sood, S.; Malhotra, M.; Das, B.K.; Kapil, A. Enterococcal infections & antimicrobial resistance. Indian J. Med. Res., 2008, 128(2), 111-121.
[PMID: 19001673]
[6]
Facklam, R.R.; Collins, M.D. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol., 1989, 27(4), 731-734.
[http://dx.doi.org/10.1128/JCM.27.4.731-734.1989] [PMID: 2656745]
[7]
Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol., 1966, 45(4), 493-496.
[http://dx.doi.org/10.1093/ajcp/45.4_ts.493] [PMID: 5325707]
[8]
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Approved standard. 27th ed; CLSI: Wayne, Pa; , 2017, pp. pp. M100-S26.
[9]
Clinical and laboratory standard Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically approved standard. 28th ed; CLSI: Wayne, PA; , 2018, 29, pp. pp. M07-A8.
[10]
Dutka-Malen, S.; Evers, S.; Courvalin, P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol., 1995, 33(1), 24-27.
[http://dx.doi.org/10.1128/JCM.33.1.24-27.1995] [PMID: 7699051]
[11]
Mendiratta, D.K.; Kaur, H.; Deotale, V.; Thamke, D.C.; Narang, R.; Narang, P. Status of high level aminoglycoside resistant Enterococcus faecium and Enterococcus faecalis in a rural hospital of central India. Indian J. Med. Microbiol., 2008, 26(4), 369-371.
[http://dx.doi.org/10.4103/0255-0857.43582] [PMID: 18974493]
[12]
Bose, S.; Ghosh, A.K.; Barapatre, R. Prevalence of Drug Resistance among Enterococcus Spp isolated from a tertiary care hospital. Int. J. Med. Health Sci., 2012, 1, 3-10.
[13]
Yadav, G.; Thakuria, B.; Madan, M.; Agwan, V.; Pandey, A. Linezolid and vancomycin resistant enterococci: A therapeutic problem. J. Clin. Diagn. Res., 2017, 11(8), GC07-GC11.
[http://dx.doi.org/10.7860/JCDR/2017/27260.10474] [PMID: 28969155]
[14]
Purohit, G.; Gaind, R.; Dawar, R.; Verma, P.K.; Aggarwal, K.C.; Sardana, R.; Deb, M. Characterization of vancomycin resistant enterococci in hospitalized patients and role of gut colonization. J. Clin. Diagn. Res., 2017, 11(9), DC01-DC05.
[http://dx.doi.org/10.7860/JCDR/2017/25988.10548] [PMID: 29207701]
[15]
Karmarkar, M.G.; Gershom, E.S.; Mehta, P.R. Enterococcal infections with special reference to phenotypic characterization & drug resistance. Indian J. Med. Res., 2004, 119(Suppl.), 22-25.
[PMID: 15232156]
[16]
Modi, G.B.; Soni, S.T.; Patel, K.J.; Goswami, H.M.; Vegad, M.M. Prevalence of vancomycin resistant enterococci in tertiary care hospital. Int. J. Microb. Res., 2012, 4, 182-185.
[http://dx.doi.org/10.9735/0975-5276.4.2.182-185]
[17]
Parameswarappa, J.; Basavaraj, V.P.; Basavaraj, C.M. Isolation, identification, and antibiogram of enterococci isolated from patients with urinary tract infection. Ann. Afr. Med., 2013, 12(3), 176-181.
[http://dx.doi.org/10.4103/1596-3519.117629] [PMID: 24005591]
[18]
Shrestha, L.B.; Baral, R.; Khanal, B. Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections. Infect. Drug Resist., 2019, 12, 957-963.
[http://dx.doi.org/10.2147/IDR.S200988] [PMID: 31118702]
[19]
Toner, L.; Papa, N.; Aliyu, S.H.; Dev, H.; Lawrentschuk, N.; Al-Hayek, S. Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom. Investig. Clin. Urol., 2016, 57(2), 129-134.
[http://dx.doi.org/10.4111/icu.2016.57.2.129] [PMID: 26981595]
[20]
Miller, W.R.; Munita, J.M.; Arias, C.A. Mechanisms of antibiotic resistance in enterococci. Expert Rev. Anti Infect. Ther., 2014, 12(10), 1221-1236.
[http://dx.doi.org/10.1586/14787210.2014.956092] [PMID: 25199988]
[21]
Moghimbeigi, A.; Moghimbeygi, M.; Dousti, M.; Kiani, F.; Sayehmiri, F.; Sadeghifard, N.; Nazari, A. Prevalence of vancomycin resistance among isolates of enterococci in Iran: a systematic review and meta-analysis. Adolesc. Health Med. Ther., 2018, 9, 177-188.
[http://dx.doi.org/10.2147/AHMT.S180489] [PMID: 30532606]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy